Asthma, Author Interviews, Brigham & Women's - Harvard, Race/Ethnic Diversity / 09.05.2021
COVID-19: Asthma Attacks Drop Dramatically Among Black & Latinx Communities During Epidemic
MedicalResearch.com Interview with:
[caption id="attachment_57391" align="alignleft" width="150"]
Dr. Salciccioli[/caption]
Justin Salciccioli, MBBS, MA
Research Fellow in Medicine
[caption id="attachment_57392" align="alignleft" width="150"]
Dr. Israel[/caption]
Elliot Israel, MD
Professor of Medicine, Harvard Medical School
Pulmonary and Critical Care, Rheumatology, Medicine
Brigham and Women's Hospital
MedicalResearch.com: What is the background for this study?
Response: Asthma attacks account for almost 50% of the cost of asthma care, which costs $80 billion each year in the United States. Asthma is more severe in African-American/Black and Hispanic/Latinx patients, with these groups having double the rates of attacks and hospitalizations as the general population. The PREPARE study is an ongoing national clinical trial for African American/Black and Hispanic/Latinx adults with moderate-to-severe asthma from different U.S. cities in which reporting of asthma control and asthma exacerbations was monitored entirely remotely.
With the arrival of the Covid19 pandemic, several studies suggested that asthma exacerbations may have decreased during the pandemic. However, multiple reports have suggested people were avoiding health services because of the pandemic, making it difficult to tell whether exacerbations truly decreased or whether people were simply avoiding their doctors. This is the first study done to assess asthma exacerbations before and during the pandemic that is unlikely to be impacted by patient healthcare avoidance.
Dr. Salciccioli[/caption]
Justin Salciccioli, MBBS, MA
Research Fellow in Medicine
[caption id="attachment_57392" align="alignleft" width="150"] Dr. Israel[/caption]
Elliot Israel, MD
Professor of Medicine, Harvard Medical School
Pulmonary and Critical Care, Rheumatology, Medicine
Brigham and Women's Hospital
MedicalResearch.com: What is the background for this study?
Response: Asthma attacks account for almost 50% of the cost of asthma care, which costs $80 billion each year in the United States. Asthma is more severe in African-American/Black and Hispanic/Latinx patients, with these groups having double the rates of attacks and hospitalizations as the general population. The PREPARE study is an ongoing national clinical trial for African American/Black and Hispanic/Latinx adults with moderate-to-severe asthma from different U.S. cities in which reporting of asthma control and asthma exacerbations was monitored entirely remotely.
With the arrival of the Covid19 pandemic, several studies suggested that asthma exacerbations may have decreased during the pandemic. However, multiple reports have suggested people were avoiding health services because of the pandemic, making it difficult to tell whether exacerbations truly decreased or whether people were simply avoiding their doctors. This is the first study done to assess asthma exacerbations before and during the pandemic that is unlikely to be impacted by patient healthcare avoidance.
